Advertisement
U.S. Markets closed
S&P Futures
6,041.25 +3.00 (+0.05%) Dow Futures
44,993.00 +42.00 (+0.09%) Nasdaq Futures
20,993.00 -0.50 (-0.00%) Russell 2000 Futures
2,437.90 +5.50 (+0.23%) Crude Oil
68.67 -0.10 (-0.15%) Gold
2,631.00 +9.70 (+0.37%)
MiNK Therapeutics, Inc. (INKT)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 0.6920 |
| Open | 0.7400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.6825 - 0.7400 |
| 52 Week Range | 0.5700 - 1.9000 |
| Volume | |
| Avg. Volume | 36,920 |
| Market Cap | 28.634M |
| Beta (5Y Monthly) | 0.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3700 |
| Earnings Date | Nov 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 |
- Thomson Reuters StreetEvents
Q3 2024 Mink Therapeutics Inc Earnings Call
Q3 2024 Mink Therapeutics Inc Earnings Call
- GuruFocus.com
MiNK Therapeutics Inc (INKT) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
MiNK Therapeutics Inc (INKT) showcases significant operational improvements and promising clinical progress, despite facing financial hurdles.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.